4D Molecular Therapeutics Inc (NASDAQ: FDMT) Is A Good Bet For Risk-Tolerant Investors
4D Molecular Therapeutics Inc (NASDAQ:FDMT)’s traded shares stood at 0.39 million during the last session, with the company’s beta value hitting 2.85. At the close